BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21330037)

  • 21. Prognostic implication of hyperglycemia in myocardial infarction and primary angioplasty.
    Worthley MI; Shrive FM; Anderson TJ; Traboulsi M
    Am J Med; 2007 Jul; 120(7):643.e1-7. PubMed ID: 17602940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
    Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
    Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study).
    Pinto DS; Kirtane AJ; Pride YB; Murphy SA; Sabatine MS; Cannon CP; Gibson CM;
    Am J Cardiol; 2008 Feb; 101(3):303-7. PubMed ID: 18237589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
    Kosiborod M; Inzucchi SE; Krumholz HM; Xiao L; Jones PG; Fiske S; Masoudi FA; Marso SP; Spertus JA
    Circulation; 2008 Feb; 117(8):1018-27. PubMed ID: 18268145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal dysfunction is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.
    Ferrer-Hita JJ; Dominguez-Rodriguez A; Garcia-Gonzalez MJ; Abreu-Gonzalez P
    Int J Cardiol; 2007 May; 118(2):243-5. PubMed ID: 16997402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of exercise stress testing versus ambulatory electrocardiography after acute myocardial infarction: a 3 year follow-up study.
    Quintana M; Lindvall K; Brolund F; Eriksson SV; Rydén L
    Coron Artery Dis; 1995 Nov; 6(11):865-73. PubMed ID: 8696531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.
    Rogers WJ; Frederick PD; Stoehr E; Canto JG; Ornato JP; Gibson CM; Pollack CV; Gore JM; Chandra-Strobos N; Peterson ED; French WJ
    Am Heart J; 2008 Dec; 156(6):1026-34. PubMed ID: 19032996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of hyperglycemia to ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction.
    Chi HJ; Zhang DP; Xu Y; Yang ZS; Wang LF; Cui L; Yang XC
    Chin Med J (Engl); 2007 Nov; 120(21):1874-7. PubMed ID: 18067758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.
    Dziewierz A; Siudak Z; Dykla D; Rakowski T; Mielecki W; Dubiel JS; Dudek D
    Kardiol Pol; 2009 Feb; 67(2):115-20; discussion 121-2. PubMed ID: 19288373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling.
    Djordjevic-Radojkovic D; Koracevic G; Stanojevic D; Damjanovic M; Apostolovic S; Pavlovic M
    Acute Card Care; 2013 Jun; 15(2):38-43. PubMed ID: 23738623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of markedly increased B-type natriuretic peptide in patients with ST-segment elevation myocardial infarction.
    Neyou A; O'Neil B; Berman AD; Boura JA; McCullough PA
    Am J Emerg Med; 2011 Feb; 29(2):141-7. PubMed ID: 20825778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction.
    Beygui F; Collet JP; Benoliel JJ; Vignolles N; Dumaine R; Barthélémy O; Montalescot G
    Circulation; 2006 Dec; 114(24):2604-10. PubMed ID: 17116769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ST-segment depression on the initial electrocardiogram in acute myocardial infarction-prognostic significance and its effect on short-term mortality: A report from the National Registry of Myocardial Infarction (NRMI-2, 3, 4).
    Pitta SR; Grzybowski M; Welch RD; Frederick PD; Wahl R; Zalenski RJ
    Am J Cardiol; 2005 Apr; 95(7):843-8. PubMed ID: 15781012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction.
    Goldberg A; Hammerman H; Petcherski S; Zdorovyak A; Yalonetsky S; Kapeliovich M; Agmon Y; Markiewicz W; Aronson D
    Am J Med; 2004 Aug; 117(4):242-8. PubMed ID: 15308433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.